B ჯგუფის სტრეპტოკოკული ინფექცია

Consultant in Microbiology and Infectious Diseases

University Hospital of Wales

Cardiff

UK

გაფრთხილება:

BH has received educational grants and fees for consultancy from a number of pharmaceutical companies, including BMS, Gilead, Jannsenn, Abbvie, ViiV, and MSD. This is principally in work relating to hepatitis C and HIV. BH has carried out consultancy work on some antibiotics, including fidaxomicin, linezolid, tedizolid, ceftobiprole, and ceftaroline. BH declares he has no competing interests in relation to the work carried out for this topic review, Group B streptococcus.

Dr Brendan Healy would like to gratefully acknowledge Dr Susannah Froude and Dr Harriet Hughes, previous contributors to this topic.

გაფრთხილება:

SF declares that she has no competing interests. HH declares that she has received funds from Gilead and Biocomposites related to conference registration, travel, accommodation, and speaker fees.

Chief and Professor of Medicine

Division of Infectious Diseases and International Health

University of Virginia Health System

Charlottesville

VA

გაფრთხილება:

WAP declares that he has no competing interests.

Assistant Professor

Pediatrics

Attending Physician

Pediatric Emergency Medicine

University of Southern Alabama Children's and Women's Hospital

Mobile

AL

გაფრთხილება:

JRH declares that he has no competing interests.